Controversies over the targets of controlling blood pressure in hypertensive patients with chronic kidney disease
10.12092/j.issn.1009-2501.2023.04.014
- Author:
Sisi NING
1
;
Yuhong ZHAO
1
;
Lei YAN
1
;
Minna TANG
2
;
Ningzhi ZHANG
3
;
Yongqiao ZHANG
3
;
Zhaoqiang CUI
3
Author Information
1. Department of internal medicine, Tianshan Hospital of traditional Chinese Medicine
2. Department of Cardiology, Sixth People's Hospital Affiliated to Shanghai Jiao Tong University
3. Shanghai Institute of Cardiovascular Disease, Department of Cardiology, Zhongshan Hospital, Fudan University
- Publication Type:Journal Article
- Keywords:
antihypertensive target;
chronic kidney disease;
hypertension
- From:
Chinese Journal of Clinical Pharmacology and Therapeutics
2023;28(4):463-467
- CountryChina
- Language:Chinese
-
Abstract:
The increasing incidence of chronic kidney disease (CKD) has become a major global public health problem. Hypertension and CKD can cause and effect each other and often coexist. Controlling blood pressure is one of the core tasks in the treatment of CKD. Over the past 10 years, many large clinical studies have provided evidence-based medical evidence for the updating and revision of hypertension management guidelines, but there remains controversies in targets of blood pressure in hypertensive patients with CKD. Personalized and evidence-based management is the key to achieve effective control of blood pressure and slow the progression of CKD. This review will summary the epidemiological status of hypertensive patients with CKD and the progress related to the targets of controlling blood pressure in CKD.
